Rifabutin

Rifabutin
(IUPAC) ime
	(9S,12E,14S,15R,16S,17R,18R,19R,20S,; 21S,22E,24Z)-6,16,18,20-tetrahidroksi-1'-; izobutil-14-metoksi-7,9,15,17,19,21,25-; hepta-metil-spiro[9,4-(epoksipentadeka; [1,11,13]trienimino)-2H-furo-[2',3':7,8]-naft; [1,2-d]imidazol-2,4'-piperidin]-5,10,26-(3H,9H)-; trion-16-acetat
Klinički podaci
Robne marke	Mycobutin
AHFS/Drugs.com	Monografija
MedlinePlus	a693009
Identifikatori
CAS broj	72559-06-9
ATC kod	J04AB04
PubChem	6323490
DrugBank	DB00615
ChemSpider	10482168
UNII	1W306TDA6S
KEGG	D00424
ChEBI	CHEBI:45367
ChEMBL	CHEMBL444633
Hemijski podaci
Formula	C46H62N4O11
Mol. masa	847,005 g/mol
SMILES	eMolekuli & PubHem
InChI
	InChI=1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,49,52-54H,16-19,21H2,1-11H3,(H,47,57)/b13-12 ,20-15 ,24-14-/t23-,25 ,26 ,27 ,30-,37-,38 ,41 ,45-/m0/s1 ; Key: ATEBXHFBFRCZMA-VXTBVIBXSA-N
Farmakokinetički podaci
Bioraspoloživost	85%
Vezivanje za proteine plazme	85%
Metabolizam	Hepatički
Poluvreme eliminacije	28 do 62 sata
Izlučivanje	Renalno i fekalno
Farmakoinformacioni podaci
Trudnoća	?
Pravni status	POM (UK), ℞-only (SAD)
Način primene	Oralno

Rifabutin (Rfb) je baktericidni antibiotički lek koji se prvenstveno koristi u tretmanu tuberkuloze.^[6]^[7] Ovaj lek je semisintetički derivat rifamicina S. Njegovo dejstvo je bazirano na blokiranju DNK-zavisne RNK-polimeraze bakterija. On je efektivan protiv Gram-pozitivnih i pojedinih Gram-negativnih bakterija, kao i protiv visoko rezistantnih Mikobakterija, e.g. Mycobacterium tuberculosis, M. leprae, i M. avium intracellulare.

Reference

↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit
↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit
↑ Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.
↑ Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948863. edit
↑ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. PMID 21059682.
↑ Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. PMID 18048412.

Spoljašnje veze

	Portal Medicina
	Portal Hemija

U.S. Patent 3,150,046 to Achifar Arhivirano 2008-09-25 na Wayback Machine-u.
Chlamydia Pneumoniae Arhivirano 2022-07-05 na Wayback Machine-u

[1] Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519. edit

[2] Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.

[3] Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846. edit

[4] Joanne Wixon, Douglas Kell (2000). „Website Review: The Kyoto Encyclopedia of Genes and Genomes — KEGG”. Yeast 17 (1): 48–55. DOI:10.1002/(SICI)1097-0061(200004)17:1<48::AID-YEA2>3.0.CO;2-H.

[5] Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948863. edit

[6] Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. PMID 21059682.

[7] Wishart DS, Knox C, Guo AC, Cheng D, Shrivastava S, Tzur D, Gautam B, Hassanali M (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. PMID 18048412.

[1]

[2]

[3]

[4]

[5]

[6]

[7]